Alfresa Holdings Corporation

In a long-running effort to balance growth in national healthcare costs in a rapidly ageing society and promote stability in a flat pharmaceutical market, Japan has announced details of its annual dru

Daiichi Sankyo Co. Ltd. has said it is not in talks to sell off its over-the-counter products subsidiary, following a media report in Japan that the operation might be divested for around $900m. A re

Japan has granted reimbursement prices to a batch of new drugs, including a new therapy for hepatitis C, a novel anticoagulant and a new insomnia treatment. Most of the products that were included in

Most of the products that will be included in the national health insurance tariff on Nov.25 were granted formal marketing approval in October ( [A#28141001001] ). The pricing will clear the way for t